Data from real world to evaluate the efficacy of osimertinib in non-small cell lung cancer patients with central nervous system metastasis

Puyuan Xing, Yuxin Mu, Xuezhi Hao, Y. Wang, Junling LiClinical 2019 · DOI

Abstract

This real-world analysis further confirmed that osimertinib indeed demonstrated clinically meaningful efficacy against CNS metastases in Chinese patients with advanced NSCLC.
BibTeX
@inproceedings{xing2019data,
  author = {Puyuan Xing and Yuxin Mu and Xuezhi Hao and Y. Wang and Junling Li},
  title = {{Data from real world to evaluate the efficacy of osimertinib in non-small cell lung cancer patients with central nervous system metastasis}},
  booktitle = {Clinical},
  year = {2019},
  doi = {10.1007/s12094-019-02071-5},
}

Loading related content...

Figure